FDA Drug recall D-093-2013
Procrit (epoetin alfa) injection, 20000 units/mL, 4 mL vial
- FDA Drug
- Class II
- terminated
- Published 2012-12-26
On 2012-12-26 the FDA classified a Class II recall of Procrit (epoetin alfa) injection, 20000 units/mL, 4 mL vial by Physicians Total Care, citing presence of Particulate Matter: glass delamination.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-093-2013 |
| Classification | Class II |
| Status | terminated |
| Initiated | 2010-10-04 |
| Published | 2012-12-26 |
| Last updated | 2026-09-13 11:51 UTC |
| Company | Physicians Total Care |
| Distribution | CA, PA |
Product
Procrit (epoetin alfa) injection, 20000 units/mL, 4 mL vial; Mfg By: Amgen Inc., Thousand Oaks, CA 91320; Dist. By: Physicians Total Care, Tulsa, OK 74146; NDC 54868-5673-1.
Reason
Presence of Particulate Matter: glass delamination
Identifiers
| code_info | Lot #: 44TK, Exp 09/10; 4NQE, Exp 05/11; 4WKN, Exp 11/11; 5KZT, 5RCM, Exp 09/12; 5RZN, Exp 10/12; 5Y8Y, 60E2, Exp 12/12 |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-093-2013%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.